Intituto Catalán de Oncología

Barcelona, Catalonia 08908

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Squamous Cell Carcinoma (HNSCC)

Studies at this site

• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling